Skip to Main Content

Greenville SC

  • sam patrick posted an article
    Assay designed for RapidRona at home tests see more

    Premier Medical Laboratory Services (PMLS), one of the largest private medical diagnostics laboratories in the US has provided results for millions of COVID-19 tests since the beginning of the pandemic, contributing largely to the national COVID-19 response. They have also implemented one of the largest variant surveillance initiatives in the country with the capability to sequence up to 42,000 specimens per day. Now, they have been granted Emergency Use Authorization (EUA) from the Food and Drug Administration to process results for at-home COVID-19 tests.

    The RT-PCR-based SARS-CoV-2 assay now authorized by the FDA is designed for RapidRona at home tests which can be ordered online at www.rapidrona.com. RapidRona enables those who would like to test for COVID-19 to collect their own sample at home by a minimally invasive nares swab and then send the specimen with prepaid shipping to the lab for processing of results. Polymerase Chain Reaction (PCR) tests have been known throughout the pandemic as the gold standard of testing methods due to the highly accurate results that they provide.  

    “Our scientists have worked diligently to take the steps necessary in receiving the EUA for this test,” said Kevin Murdock, Founder and CEO of Premier Medical Laboratory Services. “We did this because we know how important it is to enable the population to more easily access reliable COVID-19 tests with fast turnaround times from home. We’re proud that this is another way we can provide effective solutions for COVID-19 management.”

    At-home COVID-19 tests have been reported as difficult to find during the Omicron surge. The EUA attained by PMLS will allow more people the ability to test and mitigate the spread of the virus. Because some countries around the world only accept incoming travelers who have taken a RT-PCR test with a negative result, RapidRona is the choice for at-home testing among travelers. Returning schools and businesses can also reduce viral transmission rates utilizing RapidRona’s sample collection method designed for improved comfortability, keeping infected employees, students, and staff to a minimum. 

    PMLS is part of a house of brands under Diversified Medical Healthcare which manufacture testing supplies, develops medical data management software, and provides PPE to seamlessly meet the needs of organizations without delay or disruption.

    During the pandemic, PMLS has:

    • Processed millions of COVID-19 tests with a turnaround time of 24 hours or less
    • Served as the choice processing lab for Health and Human Services testing sites
    • Been the trusted COVID-19 management partner for professional sports teams, schools, colleges, large corporations, and health departments spanning from coast to coast

    To order a test, please visit www.rapidrona.com. For more information on Premier Medical Laboratory Services, please visit www.PreMedInc.com.  

    ###

    ABOUT PREMIER MEDICAL LABORATORY SERVICES: Premier Medical Laboratory Services (PMLS), based in Greenville, South Carolina, is an advanced molecular diagnostics lab fully certified by top laboratory accrediting organizations, including CLIA and COLA. With the most advanced laboratory information systems (LIS), easy to read one-page test result reports are generated with higher accuracy and a customizable report for each client. PMLS prides itself on having some of the most rapid turnaround times for testing results in the industry and patient-friendly billing. Their expansive testing menu includes advanced Cardiovascular Testing, Diabetes panels, Pharmacogenomics, COVID-19 testing, Women’s Wellness panels, Allergen Specific Ige Blood Testing, and Toxicology. For more information, please visit www.PreMedInc.com or call 1.866.800.5470.

  • sam patrick posted an article
    Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies see more

    Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former CMO of Elastrin Therapeutics, Dr. Pedro M. Quintana Diez, will act as chairman. Elastrin Therapeutics’ lead asset ELT-001 is an EDTA-loaded nanoparticle conjugated with a proprietary monoclonal antibody for the treatment of vascular calcification.

    Elastrin Therapeutics’ Scientific Advisory Board is comprised of:

    Prof. Charles O’Neill, MD: Dr. O’Neill has had an active basic and clinical research program in vascular calcification for the past 20 years and has published over 45 articles on this subject. As a practicing nephrologist, he has a particular interest in vascular calcification in patients with chronic kidney disease. Current research is aimed at approaches to assess reversibility of calcification in animal models and to slow progression of calcification by altering hemodialysis prescription in clinical trials.

    Prof. Elena Aikawa, MD, PhD: Dr. Elena Aikawa is a Professor of Medicine at Harvard Medical School, and the Naoki Miwa Distinguished Chair in Cardiovascular Medicine and the Director of Heart Valve Translational Research Program at Brigham and Women’s Hospital. She was at the forefront in the discovery of inflammation-dependent mechanisms of cardiovascular calcification. Her studies contributed to the discovery of calcifying extracellular vesicles as a precursor of microcalcification.

    Prof. Frank Rutsch, MD: Frank Rutsch is an Associate Professor in Pediatrics at Münster University Children’s Hospital, Münster, Germany. After a postdoctoral research fellowship at the University of California, San Diego, he became the leader of an independent research group at Münster University Children’s Hospital in 2004. Dr. Rutsch’s main research interests are focused on the discovery of the underlying genetic defects and translational aspects in rare pediatric metabolic and autoimmune disorders.

    Dr. Klaus-Dieter Langner: Klaus-Dieter Langner is a life science expert with more than 32 years of experience in pharmaceutical industry. Klaus started his career as research scientist at Behringwerke/Hoechst focusing on the expression of recombinant human plasma proteins and immunomodulators. After 12 years, he moved to Grünenthal where he was appointed as Head of Research. In his last position, Klaus acted as Chief Scientific Officer and Member of the Corporate Executive Board.

    Prof. Linda Hands, MD: Linda Hands was appointed Clinical Reader in the University of Oxford and Honorary Consultant Vascular surgeon in 1992 after training in London, Oxford and Chicago. She was Clinical Director of Vascular and cardiothoracic surgery for three years and also served on the Health Authority and a NICE committee. Linda retired in late 2017 as Associate Professor and remain an Hon. Emeritus Professor at the John Radcliffe Hospital Oxford and Emeritus Fellow of Green College, Oxford.

    Dr. Pedro M. Quintana Diez, M.D.: Pedro is an internal medicine doctor with over 20 years of clinical development experience in the international biotech and pharmaceutical industry. Prior to joining Elastrin Therapeutics, Pedro served as CMO of Sensory Sciences LLC and held VP and leadership positions at Grunenthal, Abbvie and ParinGenix. Pedro managed Phase II and III developments in cardiovascular and lung diseases. His experience submitting INDs and CTAs will add further value to the company’s pipeline.

    Dr. Yuri Martina, MD, MBA: Yuri has more than 20 years of experience and a strong track record in the strategic and operational leadership of all phases of clinical research and development at companies across Europe and the US. During his career, Yuri has worked actively in different therapeutic areas and he has led teams bringing multiple compounds from pre-clinical phase into clinical studies in both Europe and US, and achieved multiple successful NDA and MAA submissions and approvals.

  • sam patrick posted an article
    When it came to vaccine distribution, Softbox saved the day. see more

    When a pneumonia and meningitis immunization program needed to be rolled out worldwide, the safe transportation of vaccines was a crucial component in the process.

    The global bio-pharmaceutical company leading this initiative required a totally reliable, cost-effective Temperature Control Packaging solution to support its drive – and one that was ideal for air transportation.

    The award-winning Softbox Silverpod® range was tailor-made for just this kind of activity. Not only was the entire global distribution program completed, but it was done so without any product excursions whatsoever.

    Download the complimentary case study today, courtesy of Softbox.

  • sam patrick posted an article
    Life sciences firm seeking to add hundreds of new employees see more

    Premier Medical Laboratory Services, has recently reported a rapid increase in medical testing demands coming to their laboratory – the amount of COVID-19 tests alone being processed at their Greenville, SC facility has jumped 250% in the last two weeks. Much of this is due to the Omicron variant, which first made landfall in the US at the beginning of December and is now the dominant strain of the virus in the nation. With this influx of tests poses an immediate need for hundreds of Upstate employees to be hired at the medical laboratory. 

    “Throughout the pandemic we’ve been proactive in fulfilling our staffing needs,” said Kevin Murdock, CEO and Founder of Premier Medical Laboratory Services. “To ensure that we continue to properly meet testing demands amid this new surge, we are looking to vastly expand our team and to provide jobs in the community.”

    PMLS is a CLIA and COLA certified laboratory. They are the choice processing lab for Health and Human Services testing sites, and the trusted COVID-19 management partner for professional sports teams, schools, colleges, large corporations, and health departments across the nation. With an expanding team, they are inviting members of the Upstate community to join them in providing vital services and information, helping to battle COVID-19 and its new variants and to improve the future of healthcare with advanced medical diagnostics. Currently, the lab is looking to fill the following positions:

    Lab Data Entry Clerk

    • NO EXPERIENCE NEEDED
    • Job duties include entering patient information into a computer system, scanning barcodes, and helping with any other lab assistant needs
    • Protective gear and all training are provided by the lab

    Job Type: Part-Time; Pay: $15 per hour

    Medical Laboratory Technician

    Responsible for performing medical tests in the Molecular Lab. Does not need to be certified if a degree in Chemistry or Biology have been attained.

    Responsibilities:

    • Collect and organize blood, tissue, and other bodily fluid samples from patients
    • Prepare samples for routine testing and analysis
    • Properly record results for further analysis and easy reference
    • Monitor inventory samples and supplies
    • Maintain a clean work environment

    Qualifications:

    • You must have experience as a Medical Technologist (ASCP Certificate that is CURRENT is a plus!)
    • BS in Biology or Chemistry is also helpful
    • Familiarity with common medical terminology
    • Experience in a laboratory setting
    • Strong organizational skills

    Job Type: Full-time; Pay: $18-$22 per hour

    Medical Technologist

    Requirements:

    • ***MUST HAVE EXPERIENCE WITH MANUAL EXTRACTION PROCESSES***
    • Has earned a bachelor's degree in a chemical, physical or biological science or medical technology from an accredited institution
    • Has at least 2 years of current laboratory experience, in moderate complexity testing (Chemistry, Hematology, Urinalysis)
    • Has 2 years of laboratory training or experience in high complexity testing (Allergy and/or Molecular)

    Job Type: Full-time; Pay: $24-$28/hr


    All positions located in Greenville, SC. Please email: HR@DIVMEDINC.COM to apply.  For more information, please visit www.PreMedInc.com or call 1.866.800.5470.

    ABOUT PREMIER MEDICAL LABORATORY SERVICES

    Premier Medical Laboratory Services (PMLS), based in Greenville, South Carolina, is an advanced molecular diagnostics lab fully certified by top laboratory accrediting organizations, including CLIA and COLA. With the most advanced laboratory information systems (LIS) easy to read one-page test result reports are generated with higher accuracy and a customizable report for each client. PMLS prides itself on having some of the most rapid turnaround times for testing results in the industry. Their expansive testing menu includes Pharmacogenomics, COVID-19 testing, Advanced Cardiovascular Testing, Diabetes, Women's Wellness panels, Allergen Specific Ige Blood Testing, Toxicology, and a first of its kind predictive genetic test for type II diabetes, DIABETESPredict. For more information, please visit www.PreMedInc.com.

  • sam patrick posted an article
    Another South Carolina start-up success story see more

    Scott Pancoast believes he can put Greenville on the map with his company’s product, and he’s ready to take it to the world.

    Zylö Therapeutics is a technology startup that uses a silica powder, called Z-pods — very similar in consistency to talcum powder — to be the vehicle of transport for everything from pain relievers to pesticides. The Z-pods have far-reaching medical applications, as they’ve shown promise in promoting hair growth, treating acne, relieving pain, helping with erectile dysfunction and treating cutaneous lupus, Pancoast said.

    The company uses a small facility once owned by Michelin to manufacture and market the product. Aside from some workout equipment and a few machines lining a wall, the workshop is mostly empty, with a small adjacent laboratory where the magic happens. The company doesn’t manufacture the products that finally reach the public; they mostly work through partnerships that produce the product that gets sold to the consumer.

    The Z-pods are an amorphous sand that’s perfectly safe for human consumption, said Pancoast. As the pods are rubbed into the skin, whatever they are carrying slowly absorbs into the skin.

    The pods are also useful in pesticide applications because they don’t run off the soil easily.

    Pancoast came to the Upstate from San Diego while his son attended Furman University and fell in love with the area. After a brief stint in retirement, Pancoast joined Zylo’s original owners as to help raise funds for the company. After a few ups and downs, the owners left the business him.

    “Every day is a rollercoaster (with startups),” he said.

    Pancoast has since received several seven-figure grants to develop the technology but says traditional capital is hard to come by.

    “You get told no a lot,” he said.

    Still, the company has grown to seven employees and two independent contractors, with plenty of room for growth. He hopes to expand to 40-50 employees, build a clean room or two and continue to build capital through grants and investments.

    Z-Pod applications include:

    • Harnessing nitric oxide
    • Patchless use of CBD
    • Other pain relievers delivered without uncomfortable patches
    • Increasing the bioavailability of curcumin, a promising drug
    • Sustained pain relief with lidocaine

  • sam patrick posted an article
    Premier Medical, Clemson detect latest variant in Upstate region see more

    December 20, 2021 – Today, Premier Medical Laboratory Services (PMLS), headquartered in Greenville, SC, reports their findings that the Omicron variant is now confirmed to be present in the Upstate. The laboratory has been surveilling for Omicron and other novel variants through Next Generation Sequencing (NGS) in partnership with the Clemson University Bioengineering Department. Clemson University REDDI Lab has collected samples for COVID-19 testing from throughout the upstate community and was funded through the National Institutes of Health (NIH) to then have the COVID-19 positive specimens undergo NGS at PMLS. NGS is the process of decoding the genetic make-up of the virus to track how it is mutating and spreading throughout the population.

    “As a proactive and solutions-driven company, we implemented Next Generation Sequencing to meet the needs of our population with preparedness for novel variants like Omicron,” said Kevin Murdock, CEO and Founder of Premier Medical Laboratory Services. “Through partnerships like ours with Clemson University, we are happy to increase the amount of data for South Carolina and the entire nation which is vital for vaccine efficacy and our understanding of the virus.”

    Knowing the importance of accumulating data in the continued fight against the pandemic, PMLS implemented one of the largest sequencing initiatives among any lab in the nation – with the capability to sequence up to 42,000 samples per week. Many labs that are conducting COVID-19 testing have not developed the capabilities to conduct sequencing, and new variants cannot be fully identified via COVID-19 diagnostic testing methods alone. PMLS will continue working to uncover any further novel variants and mutations that COVID-19 presents and notify health officials.

    Other ways PMLS has helped to meet demands during the pandemic:

    • Processing lab for Human Health Services surge sites and several state health departments 
    • Blue Cross Blue Shield preferred COVID-19 testing lab in several states
    • Reached one of the highest testing capacities in the nation with the capability to process over 300,000 tests per day
    • Developed medical data management software that communicates directly from laboratory equipment for faster HIPAA compliant delivery of data to healthcare providers and patients
    • Shifted production to add in-house manufacturing of COVID-19 testing kits
    • Donated thousands of COVID-19 tests to children's diabetes summer camps throughout the nation
    • Donated hundreds of thousands of masks to local law enforcement, paramedics, fire departments, hospitals, and the Shriners organization and has provided free testing to first responders during the pandemic

    For more information, please visit www.premedinc.com or call 1.866.800.5470. 

    ABOUT PREMIER MEDICAL LABORATORY SERVICES
    Premier Medical Laboratory Services (PMLS), based in Greenville, South Carolina, is an advanced molecular diagnostics lab fully certified by top laboratory accrediting organizations, including CLIA and COLA. With the most advanced laboratory information systems (LIS) easy to read one-page test result reports are generated with higher accuracy and a customizable report for each client. PMLS prides itself on having some of the most rapid turnaround times for testing results in the industry. Their expansive testing menu includes Pharmacogenomics, COVID-19 testing, Advanced Cardiovascular Testing, Diabetes, Women's Wellness panels, Allergen Specific Ige Blood Testing, Toxicology, and highly advanced diabetes test, MDDiabeticPro. For more information, please visit www.PreMedInc.com

  • sam patrick posted an article
    Goal to be partner of choice for cold chain delivery of high value, temperature sensitive products see more

    CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced today that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe’s passive product portfolio. Together, they will provide the most comprehensive suite of thermal shipping solutions and become a one-stop-shop for all pharmaceutical cold chain shipping needs, enabling delivery of critical temperature-sensitive products, including next generation biologics, cell and gene therapy, and mRNA therapies such as the COVID-19 vaccine.

    The combined company, which will operate globally under the CSafe brand, will be the only cold chain platform with an end-to-end active air cargo and passive temperature-controlled packaging business spanning the complete spectrum of cold chain shipping solutions for the pharmaceutical and life sciences industries. Softbox’s well-regarded brands in the passive container space, such as SilverSkin, Silverpod and Tempcell, complement CSafe’s leading active product portfolio, particularly within air cargo. The acquisition will unlock opportunities for innovation as well as enhance CSafe’s sustainable and eco-friendly offerings, with new reusable and recyclable pallet and parcel solutions.

    Around the globe, a large industry pipeline of life-saving pharmaceutical therapies with strict temperature profiles is accelerating the need for reliable, temperature-controlled shipping solutions. Moreover, future pharmaceutical advances will require a new generation of qualified fit-for-purpose packaging, along with sophisticated tracking technology, that also helps customers meet their sustainability and recycling goals.

    “Through this combination, we will be the partner of choice for cold chain delivery of high value, temperature sensitive pharmaceutical therapies. Both CSafe and Softbox have proven to be reliable partners for customers seeking a secure way to deliver their life-enhancing products around the world,” said Patrick Schafer, CSafe CEO. “We’re thrilled to now offer our customers a platform that provides everything from the highest quality packaging to AI-enabled thermal and kinetic monitoring and logistics management.”

    “Our businesses are each rooted in a commitment to excellent customer service and high product quality, which made this combination a natural fit,” said Kevin Valentine, CEO of Softbox. “Together we will proudly continue to partner with our global Pharmaceutical customers to devise and deliver the best solutions for their evolving cold chain shipping needs, supporting the delivery of temperature sensitive lifesaving medicines and vaccines.

    “With the addition of Softbox’s product portfolio, CSafe strengthens its global infrastructure across air and ground while expanding its offerings for parcel delivery, all supported by the most advanced technology infrastructure,” said Todd Abbrecht, Co-CEO of Thomas H. Lee Partners, which first invested in CSafe in 2016. “We see an incredible opportunity for the combined company to serve as the international partner of choice for cold chain shipping solutions and remain on the forefront of innovation in the industry.”

    “The acquisition of Softbox advances CSafe’s strategy to be the leading cold chain solutions provider with a full suite of products and services to meet the needs of its pharmaceutical customers around the globe,” said Ben Magnano, Co-Managing Partner of Frazier Healthcare Partners. “CSafe is an excellent platform to build upon and we, alongside our partners at THL, will continue to make investments to further strengthen the Company’s leadership position in pharmaceutical cold chain.”

    As part of the acquisition, Softbox CEO Kevin Valentine will assume the role of president of CSafe’s Passive Temperature Controlled Packaging Division.

    Terms of the transaction were not disclosed.

  • sam patrick posted an article
    SC Life Science honorees prominent at state's major manufacturing conference see more

    Compliments of SCBIZ News

    Former South Carolina Secretary of Commerec Bobby Hitt was presented Human Technologies Inc. Lifetime Achievement Award today at the annual SCMEP Salute to Manufacturing Awards luncheon that caps off the S.C. Manufacturing Conference and Expo.

    The award winners were announced during a special luncheon following the two-day conference and a keynote address by Gov. Henry McMaster. The governor helped present the awards along with Rick Jenkins, group publisher of SC Biz News.

    Hitt served as secretary of the S.C. Department of Commerce from the time he was appointed by former governor Nikki Haley until his retirement earlier this year. A former journalist, his work in economic development began when he went to work for Nelson Mullins Riley & Scarborough, where he played a role in recruiting BMW Manufacturing to Spartanburg County and subsequently became one of the first BMW employees. He served as manager of public affairs for the plant until his appointment to the Commerce Department. Much of the department’s focus during his tenure was on recruiting manufacturers to the Palmetto State and growing those companies already here.  Secretary Hitt was also inducted into the SC Life Sciences Hall of Fame in 2018.

    Jenkins announced that, starting with next year’s Salute to Manufacturing luncheon, the award for lifetime achievement will be named for Chuck Spangler, the late executive director of the S.C. Manufacturing Extension Partnership. Spangler and SCMEP annually played a significant role in the overall conference and the awards ceremony.

    “It’s appropriate to name the lifetime achievement award in Chuck’s memory because he dedicated so much of his life to the service of manufacturing — to raising the industry to higher standards and bringing the rest of the state up with it,” Jenkins said. “It didn’t feel the same hosting this year’s conference without him, but the impression he and his colleagues at SCMEP made for this industry will not soon be forgotten.”

    SCMEP plays a key role in the conference, offering training courses to help make manufacturers better.

    “Every year from the stage I said manufacturers in this state have no better friend than Chuck and SCMEP, and I meant it,” Jenkins said.

    Other awards presented during the conference’s capstone luncheon included:

    • Emerging Manufacturer of the Year Awards went to Samsung Electronics Home Appliances America LLC and Advanced Metalworks LLC. Alimex Precision in Aluminum was a finalist in the category.
    • Humimic Medical was named Innovator of the Year. Finalists for the honor were Stanley Black & Decker and Nucor Steel.
    • The Outreach Award was taken home by South Atlantic Canners while Komatsu America Corp. and Savannah River Nuclear Solutions LLC were recognized as finalists.
    • Smart Move New Plant Awards were given to Leisure Pools and Spas, Mark Anthony Brewing and Niagara Bottling. The honor recognizes those companies that chose South Carolina over other locations to invest in new facilities.
    • Nephron Pharmaceuticals Corp., Santa Cruz Nutritionals and Techtronic Industries received the Smart Move SC Expansion Award. The award recognizes companies already in South Carolina that chose to spend their growth resources in the state by expanding locally.

    Pleasurecraft Engine Group won the Transformation and Operational Excellence Award. Intertape Polymer Group and Savannah River Nuclear Solutions LLC were finalists in the category.

  • sam patrick posted an article
    Clinical laboratory investing over $3 million, creating 54 new positions see more

    Luxor Scientific, LLC (Luxor), a full-service clinical laboratory serving customers nationwide, today announced plans to expand operations in Greenville County, South Carolina. The more than $3.2 million investment will create 54 new jobs.

    Luxor is a CLIA and CAP-accredited, and DEA registered full-service clinical laboratory that specializes in infectious disease, immunology, integrated oncology and genetics, chemistry and hematology research. The company is comprised of recognized experts in providing cutting-edge scientific solutions to better serve the health care community.

    “We are excited to continue Luxor Scientific’s growth and investment in Greenville. Our team has established itself as one of the best serving our community, and we are glad to be adding to our capability and to our numbers,” said Luxor Scientific, LLC Chief Strategy Officer Jay Flanagan. “We are ever thankful to Greenville County and the S.C. Department of Commerce for helping us make this expansion a reality.”

    Located at 1327 Miller Road in Greenville, Luxor’s expansion will increase the company’s research and development capacity to better serve its clientele.

    “Luxor’s expansion highlights the tremendous success life science companies are seeing throughout South Carolina,” stated South Carolina Governor Henry McMaster. “This investment will bring enhanced care and innovation to South Carolina’s health care community while also creating high-quality jobs in Greenville County.”

    Luxor was founded in 2016 by brothers Ryan and Jay Flanagan, and has grown to more than 140 employees, including world-class PhD science officers on its staff. Among their clients are S.C. Department of Health and Environmental Control (DHEC), the S.C. Department of Agriculture, the US Drug Enforcement Administration, private sector employers, hospitals, universities, clinics, and others.

    “When companies like Luxor Scientific operate in South Carolina and find success, it highlights the diversity of our state’s economy. We congratulate Luxor on this expansion in Greenville County and look forward to watching their continued work in South Carolina,” added Secretary of Commerce Harry M. Lightsey III.

    The latest expansion is expected to be completed by April 2022. Individuals interested in joining the Luxor team should visit the company’s contact webpage.

    “We are always pleased when a homegrown company like Luxor chooses to expand here in Greenville County, commented Greenville County Council Chairman and Greenville Area Development Corporation Board Member Willis Meadows. “Luxor’s leading-edge expertise in life sciences has made them a strong resource to our state and to communities across the country already, and we are delighted that they have chosen to continue that growth from right here in Greenville County.”

    # # #

    The Greenville Area Development Corporation is a non-profit organization established by Greenville County Council to promote and enhance the economic growth and development of Greenville County. Since its founding in 2001, GADC efforts have resulted in the creation of over 30,000 new jobs, nearly $6 billion in capital investment, and a cumulative economic impact of over $55 billion in Greenville County, SC -- including an economic impact of more than $6 billion annually. To learn more, please visit www.goGADC.com or call (864) 235-2008. To learn more about workforce opportunities, visit www.jobsingreenvillesc.com.

  • sam patrick posted an article
    Robert and Margaret Hill create Furman endowment see more

    It’s easy to get Robert Hill ’83 talking fondly about his alma mater.

    “It’s fun to talk about Furman,” says the retired executive and member of the Furman Board of Trustees. “I think it’s a really special place. It’s a great school with strong leadership.”

    Hill and his wife, Margaret Hill ’83, have shown their dedication to their university in many ways through the years, including service as past chairs of the Richard Furman Society executive committee and past members of the Because Furman Matters Campaign executive committee. The Hill Atrium and Hill Courtyard of the Trone Student Center are named in their honor, as is a biogeochemistry lab in the Townes Center for Science. They also support the Partners Scholarship Program and the Cothran Center for Vocational Reflection.

    And now they are supporting the Institute for Innovation and Entrepreneurship with an endowment fund. To recognize that commitment, the institute will be known as The Robert and Margaret Hill Institute for Innovation and Entrepreneurship.

    Anthony Herrera, Furman’s chief innovation officer and executive director of The Institute of Innovation and Entrepreneurship.

    The naming is fitting, says Anthony Herrera, Furman’s chief innovation officer and executive director of The Hill Institute, noting the Hills’ initial “seed” investment that prompted the institute’s founding.

    “They were such a catalyst in getting the university to take the first step to launch this institute,” Herrera says. “They started the journey that brought me to campus to take this role on. Not only have they been supporters, they’ve been partners in building it step by step and brick by brick.”

    The Hill Institute was launched in August 2018 with Herrera’s hiring. With the mission of developing leaders into entrepreneurially minded thinkers and doers, the institute has helped introduce the Furman Business Innovation Accelerator, the GVL Starts program, the Class E podcast and the Paladin Pitch competition.

    These accomplishments, and the success of The Hill Institute as a whole, have their roots in The Furman Advantage, says Robert Hill.

    “I think that really enables us to do some neat things as a university and invest in our student body appropriately,” he says. “That’s an important anchor – and I’m not sure we’d invest if we didn’t have a healthy strategy around The Furman Advantage and creating those experiences for students.”

    The Hills’ endowment will allow the institute to continue its ongoing work and create more connections across campus, Herrera says.

    “When you think about a domain that can connect chemistry and communication studies, or philosophy and business – that’s innovation and entrepreneurship,” he says. “That’s where the institute is so transformational.  This will bring all the departments, all the disciplines, all of our divisions across campus together in a common ground. We’re just barely starting to scratch the surface.”

    Herrera’s leadership, as well as that of Furman President Elizabeth Davis, is inspiring to the Hills, they say.

    “The Hills have worked tirelessly to position the institute to have a continued, significant impact on the student experience and in the Greenville community, as well as in South Carolina and beyond,” said Furman University President Elizabeth Davis. “The Hills’ commitment will establish a significant foundational endowment for the institute that will help it to build on and expand its efforts. We are immensely grateful for their support.”

    “When you’re making a gift to Furman, you’re investing behind people, too,” Robert Hill says.

    As Furman alums and parents – their son, Marshall Hill, graduated in 2012 – “Furman has been good to us through the years,” Hill says.

    “A little bit of this is giving back to people who gave to us when we were students there,” he says. “We were impacted by great professors, and we made great friends at Furman, and that’s been uplifting, too. It’s an important time to give back.”

  • sam patrick posted an article
    Poly-Med welcomes Governor to Upstate see more

    Governor Henry McMaster visited with state leaders and the executive leadership team of Poly-Med, Inc.’s at its newest facility located just outside of Greenville, SC last week.  Governor McMaster’s visit was aimed at taking stock of the ever-growing biomedical industry and Poly-Med’s growing presence in the medical device industry right here in the Upstate.

    In 2019, Poly-Med, Inc., the leader in bioresorbable materials and medical device development, opened a state of the art development and production facility doubling their footprint in the Upstate.  The new facility greatly expands PMI’s capabilities to offer medical device development for  medical-grade electrospinningextrusion, additive manufacturing, and technical textile processes in a certified ISO Class 8 environment. 

    Governor McMaster was encouraged by the growth of the company and the technological advancements that Poly-Med has achieved in recent years of utilizing resorbable materials to expand medical device and implant functionality.  The Governor and many others at the state level are encouraging manufacturing investment in the life sciences and biomedical industries within the State. During his visit, the Governor toured Poly-Med’s facility and evaluated its innovative technologies used to produce implants that act as a natural scaffold in the body to replace damaged or diseased tissues.

    Poly-Med’s President, David Shalaby, stated “Poly-Med is a solutions’ driven organization that is working on the next class of medical devices.  The expansion of our facilities demonstrates Poly-Med’s dedication to build an infrastructure for custom medical device development within South Carolina. Our focus within the specialty resorbable material field continues our long history of designing and delivering first in class products. We look forward to growing our presence in South Carolina to support our clients in their medical device design and resorbable implant needs that improve the quality of life for patients.” 

    The expansion of Poly-Med’s facilities is an investment in the ever-growing life sciences community in the Southeast, particularly in South Carolina. South Carolina is home to a $12+ Billion industry with over 700 dedicated life science firms. To learn more about Poly-Med or the opening of the new facility, please contact Poly-Med.

     

    About Poly-Med, Inc.

    For the past 28 years, Poly-Med has developed first in class innovative medical implants that improve the quality of life for patients.  Poly-Med’s mission is to drive innovation in the biomedical industries that positively impact human health.

  • sam patrick posted an article
    Investment from large investors attracted into SMO industry see more

    Velocity Clinical Research ("Velocity") today announces it has acquired two multi-site companies, VitaLink Research ("VitaLink") and the National Research Institute ("NRI"), for an undisclosed amount. The double acquisition adds 11 sites to Velocity's existing 18, making it the largest fully integrated site management organization in the world and signaling the next phase in the evolution of the industry.

    South Carolina-based VitaLink Research operates a network of six (6) sites in the central and western part of the state, including the Greenville/Spartanburg corridor. California-based National Research Institute has five (5) facilities in the greater Los Angeles area. The combination of VitaLink and NRI will further boost Velocity's therapeutic reach and recruiting power. Velocity's goal to reach more minority populations is particularly enhanced through NRI's Los Angeles-area locations and bilingual staff.

    Dr G. Paul Evans, Chief Executive and President of Velocity Clinical Research, said: "Velocity has moved into the next phase of its development. We have accelerated the pace of site acquisitions this year, bringing VitaLink and NRI's experience into our fully integrated site network.

    "When consolidators start buying up the consolidators, it signals a maturing market. The clinical trials site landscape is going to look very different a year from now. We anticipate most of the large site organisations will change ownership in the coming months, as large investors take an increased interest in the sector."

    Velocity will provide additive business development effort and streamlined service delivery to VitaLink and NRI, which have already demonstrated they can perform well in high volume studies. Combined, the companies will multiply their strengths with enhanced therapeutic expertise and shared operational functions. Prior to acquisition, Velocity, VitaLink, and NRI independently enrolled over 10% of the COVID vaccine volunteers in the U.S.

    Evans added: "Patient recruitment is a key factor in speeding up drug development. The site management industry attempted to consolidate back in the 90s but this time, it's different. The focus now is on site integration rather than affiliation, allowing for greater control and leading to more efficient data collection and delivery.

    "The race to find a COVID vaccine provided impetus to speed up clinical research and demonstrated the benefit it has in getting drugs to market faster. Our goal is to offer big pharma companies access to a range of integrated sites that have a range of therapeutic capabilities through one single contact point, making site selection easier. This will ultimately change the way pharmaceutical companies approach global drug development and the reason why we believe more capital is flowing into the sector now."

    Management from both companies will occupy key roles within Velocity, strengthening its senior management bench. Steve Clemons, CEO of VitaLink, is Velocity's new SVP of Client Delivery. Samira Moran, CEO of NRI, is Velocity's new SVP of Specialist Care Delivery.

    All of Velocity's sites are fully integrated via a centralized infrastructure and common technology backbone, allowing for superior patient enrollment and consistent, high quality data delivery.

    Notes to editors:

    • A full list of Velocity's sites can be found on its website.
    • Velocity has extensive experience in vaccines, general medicine, neurology, dermatology, endocrinology, gastroenterology, and women's health.

    About Velocity Clinical Research

    Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states.

    We place the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information visit our website at https://velocityclinical.com.

    About VitaLink Research

    Founded in 2004, VitaLink has six dedicated sites in South Carolina: Greenville, Spartanburg, Union, Gaffney, Anderson, and Columbia. They specialize in vaccines, dermatology, respiratory and pulmonary diseases, women's health, and internal medicine, with over 31,000 volunteers in their database. https://vitalinkresearch.com

     September 24, 2021
  • sam patrick posted an article
    Makes top list for fifth year in a row see more

    For the fifth consecutive year, Furman University is one of the “Most Innovative Schools” among national liberal arts colleges and universities, according to the U.S. News & World Report “Best Colleges” rankings released Sept. 13. Furman also was included in the top-50 among its peers for undergraduate teaching, first-year experience and undergraduate research.

    Overall, Furman climbed six places to No. 46 among all “National Liberal Arts Colleges,” placing it again in the top quarter of all liberal arts and sciences universities. The top-ranked university in South Carolina, Furman ranks sixth in the Southeast in its category, behind the U.S. Naval Academy in Maryland (6), Washington and Lee University in Virginia (11), Davidson College in North Carolina (13), the University of Richmond (22) and Berea College in Kentucky (30).

    “Furman faculty and staff demonstrate every day their commitment to helping all of our students find their pathway through their four years at Furman by integrating curricular, co-curricular and extra-curricular experiences,” said Elizabeth Davis, president of Furman University. “These rankings, and the recognition by university leaders across the country, reflect the value of a Furman education and our innovation in delivering it.”

    Furman has been voted a “Most Innovative School” by its peers every year since launching The Furman Advantage in 2016, coming in at No. 32 this year. Furman was also recognized among its peer universities for “Best College for Veterans” (2) and “Undergraduate Teaching” (46), and among all universities for “Best First-Year Experience” (49) and “Undergraduate Research” (46). Furman also ranked No. 37 for faculty resources and No. 50 for financial resources for students.

    The “most innovative,” “undergraduate teaching,” “first-year experience” and “undergraduate research” rankings are decided by university presidents, provosts and deans of admissions who are asked to rank the top schools that come to mind in the respective categories.

    Also this year, Furman was included among “The Best 387 Colleges” in the country by The Princeton Review. The publication also ranked Furman No. 15 on its list of “schools for making an impact” in its “Best Value Colleges” guide.

    In 2020, Furman was the top college or university in South Carolina in the Best Colleges 2021 rankings by The Wall Street Journal and Times Higher Education. Furman ranked No. 135 out of nearly 800 U.S. colleges or universities that made the list. The WSJ/THE College Ranking is designed to “put graduate success and student learning at its heart.”

    For more information, contact the Furman News and Media Strategy office at 864-294-3107.

     September 24, 2021
  • sam patrick posted an article
    Two life sciences companies make list for SCRA support see more

    Compliments of Midlands Biz

    Advent Innovations, LLC and DPX Technologies, LLC have been accepted as South Carolina Research Authority (SCRA) Member Companies and awarded grant funding. Parimer Scientific, LLC and Prewrite, Inc. have been accepted as Member Companies. As Member Companies, they will receive coaching, access to experts in SCRA’s Resource Partner Network, eligibility to apply for grant funding, and the potential to be considered for an investment from SCRA’s affiliate, SC Launch, Inc.

    Advent Innovations Limited Company has been accepted as an SCRA Member Company and awarded a $50,000 Federal Matching Grant. The University of South Carolina-affiliated startup provides services in modeling, analysis, design, and product development using cutting-edge research with novel sensors, big data analytics, and other smart technology such as robotics. Their customers include private corporations and government entities in aerospace, automotive, civil infrastructure, and energy.

    DPX Technologies, LLC has been accepted as an SCRA Member Company and awarded a $50,000 Federal Matching Grant. The University of South Carolina-affiliated company manufactures sample lab preparation products and develops custom methods for a diverse client base. Their proprietary and patented INTip™ technologies provide efficient, automated solutions for laboratories that are easy to customize and implement with any workflow or method.

    Parimer Scientific, LLC has been accepted as an SCRA Member Company. The Easley-based company provides turn-key laboratory services at competitive rates to biotech and pharmaceutical companies with no upfront capital or long-term commitment needed. In 2020 alone, more than 10,000 units of pharmaceutical products were made at Parimer and shipped directly to the end-users at hospitals, doctor’s offices, and nursing homes.

    Prewrite, Inc. has been accepted as an SCRA Member Company. The Greenville-based startup offers a story development platform for writers, producers, and content creators of all types. Their powerful tool ensures the writer is using good story fundamentals. Stories of any complexity are easily built, piece-by-piece. Originally designed for screenplays, Prewrite is used around the world by professionals and amateurs alike.

    SCRA welcomes these new Member Companies!

    Grant funding is made possible, in part, by Industry Partnership Fund (IPF) contributions that fuel the state’s innovation economy. Contributors to the IPF receive a dollar-for-dollar state tax credit, making it an easy and effective way to help one of the fastest growing segments of the South Carolina economy. Grant funding for Member Companies creates a direct, positive economic effect and job creation.

    About SCRA
    https://scra.org/
    Chartered in 1983 by the State of South Carolina as a public, nonprofit corporation, South Carolina Research Authority (SCRA) fuels South Carolina’s innovation economy through the impact of its four programs. SC Academic Innovations provides funding and support to advance translational research and accelerate the growth of university-based startups. SC Facilities offers high-quality laboratory and administrative workspaces for technology-based startups and academic institutions. SC Industry Solutions facilitates and funds partnerships between and among startups, industry, and academia. SC Launch mentors and funds technology-based startups that may also receive investments from SCRA’s investment affiliate, SC Launch, Inc.

     September 08, 2021
  • sam patrick posted an article
    Furman commitment to Greenville and South Carolina growing see more

    Compliments Furman University News

    Furman is expanding its downtown presence – and planning one of the school’s greatest investments in the Greenville community – with the addition of a 2,000-square-foot space on the ground floor of 101 N. Main St. in One City Plaza.

    The storefront suite in the former Bank of America building next to Methodical Coffee is being designed as “an experiential learning environment,” said Anthony Herrera, Furman’s chief innovation officer and executive director of The Institute for Innovation and Entrepreneurship.

    “This will be one of our most visible commitments to connect Furman’s main campus with the local community,” he said.

    The One City Plaza location is the latest example of Furman’s growing presence and engagement with the community, said Liz Seman, chief of staff and liaison to Furman’s Board of Trustees.

    “From the West End to Heritage Green, to our beautiful campus on Poinsett Highway, Furman is proud to be Greenville’s University,” said Seman. “We are excited to add the space at One City Plaza to our downtown footprint. Students, faculty, staff and alumni will now have the opportunity to engage with the Greenville community at Fluor Field, M. Judson Booksellers, the Upcountry History Museum and the Bon Secours Wellness Arena. All of these venues provide unique opportunities for collaboration and high-impact experiences, which are the hallmark of The Furman Advantage.”

    A multipurpose area with flexible furniture, the space will be quickly convertible to host a wide array of programs, workshops and events, Herrera said. Select graduate and undergraduate courses, continuing education certificates, workshops, speaker series and networking events will be delivered throughout the week to develop leaders and “lifelong learners” throughout the city.

    Along with the Institute for Innovation and Entrepreneurship, Furman’s three other institutes – The Riley InstituteThe Shi Institute for Sustainable Communities and The Institute for Advancement of Community Health – will offer programming. Furman’s Center for Corporate and Professional Development and the Osher Lifelong Learning Institute, as well as the school’s academic, alumni relations and athletics departments, will also present events.

    The facility, expected to open later this year or soon after the new year, can benefit both Furman and Greenville by encouraging students to ultimately get full-time positions and stay in the city, said Herrera.

    “This space will connect our students and faculty more intentionally with the business and nonprofit community for a pipeline of talent for internships, full-time jobs, research and impactful collaborations,” he said. “It will further carry out Furman’s mission of delivering transformative experiences for lifelong learners. We want to expand our commitment to serving the Greenville community and ensuring Greenville continues to thrive.”

    Another catalyst for the development is this fall’s launch of the GVL Starts program, an eight-week program for aspiring entrepreneurs to network and learn skills to develop their potential startups and small businesses, he said.

    The ground floor space won’t be the only place to find Furman purple in the former Bank of America building. In December 2020, Furman University President Elizabeth Davis announced that the Institute for Innovation and Entrepreneurship will join the city of Greenville’s economic development team in locating offices in downtown Greenville with NEXT, an entrepreneurial-support organization that operates under the Greenville Chamber Foundation, on the third floor of 101 N. Main St.

     September 02, 2021